logo
Select company
Select metric
Ticker Information

Ticker

TSBX

Company Name

TURNSTONE BIOLOGICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TURNSTONE BIOLOGICS CORP - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSBX - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -45.45M0%$ 0
3/31/2025$ -57.07M0%$ 0
12/31/2024$ -67.44M0%$ 0
9/30/2024$ -66.47M0%$ 0
6/30/2024$ -67.68M0%$ 0
3/31/2024$ -66.44M0%$ 0
12/31/2023$ -66.15M-342.65%$ 19.31M
12/31/2022$ -71.06M-96.95%$ 73.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for TURNSTONE BIOLOGICS CORP is calculated as follows: CF - Operations [ $ -71.06M ] / Revenues [ $ 73.3M ]
(=) OCF % [ -96.95% ]

TSBX - Operating Cash Flow Margin, Last 5 years

-342.65%

Minimum

Dec 31, 2023

-96.95%

Maximum

Dec 31, 2022

-219.8%

Average

-219.8%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%